| Financial Year |
March 31 2023 |
| Monetary Funds |
8,992,786,022.25 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
57,246,776.07 |
| Accounts Receivable |
2,951,200,454.68 |
| Advances to Suppliers |
72,557,957.99 |
| Other Receivables |
48,053,604.93 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
3,715,186,915.68 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
328,983,338.53 |
| Total Current Assets |
16,179,237,141.46 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
812,768,790.06 |
| Investment Properties |
1,583,802,900.00 |
| Fixed Assetes |
4,392,437,520.98 |
| Under-construction Projects |
3,008,697,528.08 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
581,362,545.52 |
| R&D expenses |
13,876,070.93 |
| Goodwill |
10,313,565.41 |
| Long-Term Deferred and Prepaid Expenses |
181,911,989.75 |
| Deferred Income Tax Assets |
118,227,631.78 |
| Other Non-Current Assets |
160,400,013.09 |
| Sub-Total of Non-Current Assets |
11,479,812,688.59 |
| Total Assets |
27,659,049,830.05 |
| Short-Term Loans |
8,117,739,763.30 |
| Trading Financial liabilities |
-- |
| Notes Payable |
700,000,000.00 |
| Accounts Payable |
1,707,124,412.80 |
| Accounts Received In Advance |
28,791,780.98 |
| Employee Compensation Payable |
185,053,513.23 |
| Taxes Payable |
272,157,403.97 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
448,502,585.82 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
342,058,030.22 |
| Other Current Liabilities |
44,203,218.81 |
| Sub-Total of Current Liabilities |
12,593,018,439.43 |
| Long-term Loans |
2,501,168,830.56 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
1,934,295.31 |
| Deferred Income Tax Liabilities |
297,656,034.89 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
2,996,648,752.60 |
| Total Liabilities |
15,589,667,192.03 |
| Paid-In Capital(Or Share Stock) |
1,560,587,588.00 |
| Capital Surplus |
2,140,239,969.66 |
| Surplus Reserve |
1,106,956,517.38 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
5,150,553,098.92 |
| Minority Stockholder's Interest |
1,668,326,990.70 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
10,401,055,647.32 |
| Owner's Equity（Stockholder's Equity） |
12,069,382,638.02 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
27,659,049,830.05 |
